NDM-1- and OXA-23-producing Acinetobacter baumannii isolated from Intensive Care Unit patients in Tunisia

Acinetobacter baumannii has become a troublesome emerging pathogen because of its wide range of resistance determinants and its environmental resilience [1]. It is responsible for severe nosocomial infections in intensive care unit (ICU) patients, mainly ventilator associated pneumonia, bacteremia, and central nervous system infections [2,3]. Most of A. baumannii strains are multidrug-resistant (MDR) [1] and have become endemic in several healthcare environments, often causing sustained outbreaks.

Source: International Journal of Antimicrobial Agents - April 14, 2018 Category: Drugs & Pharmacology Authors: Elaa Maamar, Carla Andrea Alonso, Sana Ferjani, Ali Jendoubi, Zaineb Hamzaoui, Alia Jebri, Mabrouka Saidani, Salma Ghedira, Carmen Torres, Ilhem Boutiba-Ben Boubaker Source Type: research